市場調查報告書
商品編碼
1518357
負壓傷口治療 (NPWT) 市場:依產品類型、傷口類型和最終用戶 - 2030 年全球預測Negative Pressure Wound Therapy (NPWT) Market By Product (Conventional/Traditional, Single-use, Accessories), Wound Type (Diabetic Foot Ulcer [DFU], Venous Leg Ulcer, Surgical, Burn, Skin Grafts), End User (Hospital, Home Care) - Global Forecast to 2030 |
負壓傷口治療 (NPWT) 市場預計到 2030 年將達到 40.4 億美元,2023 年至 2030 年複合年增長率為 6%。
經過全面的一手和二手研究以及對市場情景的詳細分析,該報告包括對主要市場驅動因素、限制因素、機會和課題的分析。該市場的驅動因素包括糖尿病和慢性傷口盛行率的增加、老年人口的增加、有利的報銷政策以及肥胖及其相關併發症發生率的增加。然而,NPWT 設備的高成本以及與使用 NPWT 設備相關的併發症風險限制了市場成長。
此外,負壓傷口治療設備和新興國家的技術進步預計將為該市場的參與者提供成長機會。然而,醫療保健專業人員的認識和培訓有限以及患者因不適而不堅持治療是影響市場成長的主要課題。
以產品來看,傳統 NPWT 裝置預計在 2023 年佔據負壓傷口治療市場的最大佔有率。傳統的 NPWT 設備通常由真空幫浦、管道和敷料組成,可在傷口部位產生負壓或吸力以促進癒合。 NPWT 設備在醫院中廣泛用於治療各種類型的傷口,經過驗證的臨床結果以及醫療保健專業人員對傳統 NPWT 設備的偏好,使得該細分市場擁有巨大的市場佔有率。
依傷口類型劃分,糖尿病足潰瘍預計將在 2023 年佔據負壓傷口治療市場的最大佔有率。此細分市場的重要市場佔有率歸因於糖尿病和相關糖尿病足潰瘍盛行率的增加、患者意識的提高以及 NPWT 設備在治療糖尿病足潰瘍方面的臨床效果得到證實。
從最終用戶來看,醫院和診所預計將在 2023 年佔據負壓傷口治療市場的最大佔有率。該細分市場的巨大市場佔有率歸因於醫院擴大採用 NPWT、醫療保健專業人員對 NPWT 的好處的高度認識以及患者數量的增加。
對負壓傷口治療市場區域狀況的詳細分析提供了五個主要區域(北美、歐洲、亞太地區、中東和非洲、拉丁美洲)和主要國家覆蓋的詳細定性和定量見解。
到 2023 年,北美預計將佔據負壓傷口治療市場的最大佔有率,其次是歐洲和亞太地區。北美的巨大市場佔有率歸因於該地區先進的醫療基礎設施、主要市場參與者的存在以及對 NPWT 在慢性傷口管理方面的益處的高度認識。
Negative Pressure Wound Therapy (NPWT) Market Size, Share, Forecast, & Trends Analysis by Product (Conventional/Traditional, Single-use, Accessories), Wound Type (Diabetic Foot Ulcer, Venous Leg Ulcer, Surgical, Burn), End User - Global Forecast to 2030
The negative pressure wound therapy market is projected to reach $4.04 billion by 2030, at a CAGR of 6% from 2023 to 2030.
Following comprehensive primary and secondary research and an in-depth analysis of the market scenario, this report provides an analysis of the key market drivers, restraints, opportunities, and challenges. This market is driven by the increasing prevalence of diabetes and chronic wounds, the rising elderly population, favorable reimbursement policies, and the increasing incidence of obesity and associated comorbidities. However, the high costs of NPWT devices and the risk of complications with the use of NPWT devices restrain the growth of this market.
Furthermore, technological advancements in negative pressure wound therapy devices and emerging economies are expected to provide growth opportunities for the players in this market. However, healthcare professionals' limited awareness and training and patients' lack of adherence to treatment due to discomfort are major challenges impacting market growth.
Based on product, in 2023, the conventional/traditional NPWT devices segment is expected to account for the largest share of the negative pressure wound therapy market. Conventional NPWT devices typically consist of a vacuum pump, tubing, and dressing materials, which create negative pressure or suction at the wound site to facilitate healing. Factors such as the widespread use of NPWT devices in hospitals for the treatment of various types of wounds, proven clinical outcomes, and the high preference for conventional NPWT devices among healthcare professionals contribute to the large market share of this segment.
By wound type, in 2023, the diabetic foot ulcers segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to the increased prevalence of diabetes and associated diabetic foot ulcers, rising awareness among patients, and proven clinical outcomes of NPWT devices in treating diabetic foot ulcers.
Based on end user, in 2023, the hospital & clinics segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to the increased adoption of NPWT in hospitals, high awareness about the benefits of NPWT among healthcare professionals, and the rising patient population.
An in-depth analysis of the geographical scenario in the negative pressure wound therapy market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.
In 2023, North America is expected to account for the largest share of the negative pressure wound therapy market, followed by Europe and Asia-Pacific. North America's large market share is attributed to the region's advanced healthcare infrastructure, the presence of key market players, and high awareness regarding the benefits of NPWT in chronic wound management.
The key players operating in the negative pressure wound therapy market are Acelity L.P. Inc. (U.S.), Cardinal Health, Inc. (U.S.), Convatec Group plc (U.S.), DeRoyal Industries, Inc. (U.S.), Genadyne Biotechnologies, Inc. (U.S.), Medela AG (Switzerland), Molnlycke Health Care AB (Sweden), Smith & Nephew plc (U.K.), PAUL HARTMANN AG (Germany), and Talley Group Ltd (U.K.).
Negative Pressure Wound Therapy Market-by Product
Negative Pressure Wound Therapy Market-by Wound Type
Note: Other wound types include pressure ulcers, wounds from infections, and traumatic wounds.
Negative Pressure Wound Therapy Market-by End User
Note: Other end users primarily include long-term care facilities, ambulatory surgical centers, and rehabilitation centers.
Negative Pressure Wound Therapy Market-by Geography